An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas



Status:Recruiting
Conditions:Lymphoma
Therapuetic Areas:Oncology
Healthy:No
Age Range:15 - Any
Updated:9/27/2018
Start Date:December 18, 2015
End Date:February 13, 2020
Contact:Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:
Email:Clinical.Trials@bms.com

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase I/ II Study to Evaluate the Safety and Preliminary Efficacy of Nivolumab in Combination With Brentuximab Vedotin in Subjects With Relapsed Refractory Non Hodgkin Lymphomas With CD30 Expression (CheckMate 436: CHECKpoint Pathway and Nivolumab Clinical Trial Evaluation 436)

The purpose of this study is to determine whether Nivolumab, in combination with brentuximab
vedotin, is safe and effective in patients with certain subtypes of non-Hodgkin's lymphomas
with CD30 expression that have not responded to treatment or have come back. The subtypes we
are studying are Diffuse Large B-Cell Lymphoma (DLBCL), Peripheral T-Cell Lymphoma (PTCL),
Cutaneous T-Cell Lymphoma (CTCL), Primary Mediastinal Large B-Cell Lymphoma (PMBL) and
Mediastinal Gray Zone Lymphoma (MGZL).


For more information regarding BMS clinical trial participation, please visit
www.BMSStudyConnect.com

Inclusion Criteria:

- Relapsed/refractory diffuse large B cell lymphoma (DLBCL), relapsed/refractory
peripheral T cell lymphoma (PTCL) (all subtypes excluding anaplastic large cell
lymphoma), relapsed/refractory Cutaneous T cell lymphoma (CTCL) mycosis
fungoides/sezary syndrome (MF/SS), relapsed/refractory primary mediastinal B lymphoma
(PMBL), and relapsed/refractory mediastinal gray zone lymphoma (MGZL)

- Expression of CD30

- Subjects must be 18 years or older (≥ 15 years for PMBL)

Exclusion Criteria:

- Known central nervous system (CNS) lymphomas; Active cerebral/meningeal disease
related to the underlying malignancy

- Active, known, or suspected autoimmune disease
We found this trial at
18
sites
Washington University School of Medicine
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Phone: 314-747-8064
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
University of Alabama at Birmingham
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
Phone: 205-975-2076
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
University of Chicago
5801 South Ellis Avenue
Chicago, Illinois 60637
 773.702.1234
Phone: 773-702-0342
University of Chicago One of the world's premier academic and research institutions, the University of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Providence Portland Medical Center
4805 Northeast Glisan Street
Portland, Oregon 97213
(503) 215-1111
Phone: 503-216-3067
Providence Portland Medical Center We strive to give those we serve exceptional, compassionate health care...
?
mi
from
Portland, OR
Click here to add this to my saved trials
University of Rochester
60 Crittenden Blvd # 70
Rochester, New York 14642
(585) 275-2121
Phone: 585-276-8333
University of Rochester The University of Rochester is one of the country's top-tier research universities....
?
mi
from
Rochester, NY
Click here to add this to my saved trials
Seattle Cancer Care Alliance
825 Eastlake Ave E
Seattle, Washington 98109
(206) 288-7222
Phone: 206-288-6787
Seattle Cancer Care Alliance Seattle Cancer Care Alliance (SCCA) is a cancer treatment center that...
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Winship Cancer Institute
Atlanta, Georgia 30322
Phone: 404-778-3935
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Levine Cancer Institute
Charlotte, North Carolina 28211
Phone: 980-442-2011
?
mi
from
Charlotte, NC
Click here to add this to my saved trials
Ohio State University Comprehensive Cancer Center
Columbus, Ohio 43210
Phone: 614-366-0855
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Bon Secours St. Francis Hospital
Greenville, South Carolina 29601
Phone: 864-546-3699
?
mi
from
Greenville, SC
Click here to add this to my saved trials
Local Institution
Hackensack, New Jersey 07601
?
mi
from
Hackensack, NJ
Click here to add this to my saved trials
University of Miami, Sylvester Comprehensive Cancer Center
1475 NW 12th Ave
Miami, Florida 33136
(305) 243-1000
Phone: 305-243-7648
University of Miami, Sylvester Comprehensive Cancer Center Sylvester Comprehensive Cancer Center integrates all cancer-related activities...
?
mi
from
Miami, FL
Click here to add this to my saved trials
Icahn School of Medicine at Mount Sinai
1428 Madison Ave
New York, New York 10029
(212) 241-6500
Phone: 212-824-8583
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai is...
?
mi
from
New York, NY
Click here to add this to my saved trials
Memorial Sloan Kettering Cancer Center
1275 York Ave
New York, New York 10021
(212) 639-2000
Phone: 212-639-4839
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials
Stephenson Cancer Center
Oklahoma City, Oklahoma 73104
Phone: 405-271-4022
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The Mayo Clinic
Rochester, Minnesota 55905
Phone: 507-284-0923
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Moffitt Cancer Center
Tampa, Florida 33612
Phone: 813-745-1706
?
mi
from
Tampa, FL
Click here to add this to my saved trials
BC Cancer Agency - Vancouver Centre
Vancouver, British Columbia
Phone: 60487760002738
?
mi
from
Vancouver,
Click here to add this to my saved trials